StockWatch
·

One Point One Solutions Ltd Q2 FY27 Results

ONEPOINTQ2 FY27 Results
Filing
Result:Steady· Market: Flat

Outlook: Optimistic · Guidance: Maintained

MetricValue (₹ Cr)vs Q1 FY27
Revenue174.9610.5%
Total Income178.2110.1%
Expenditure152.547.8%
PBT25.6725.6%
Net Profit18.4112.8%
OPM24.04%1.43pp
NPM10.33%0.26pp
EPS0.7012.9%
View full financials

No YoY comparison is available to judge revenue/EBIT growth, and with reasonable but unremarkable OPM (24%) and NPM (10.3%) for an IT/BPO services business, the quarter reads as in-line rather than a standout.

ONE POINT ONE SOLUTIONS LTD · QQ2 FY-2027 · THE CALL

147% YoY growth; margins held despite Netcom; H2 guidance vague

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

10 Nov 2026 · 6 min read
Verdict

Hold

confidence 7/10

Credibility

Grade B

Hit H1 growth (138% YoY) and margin targets (25.4%). Netcom cost disclosed transparently. Prior 'doubling' guidance implicitly maintained but not formally reaffirmed.

Short-term outlook

Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

Exceptional 147% YoY growth and sustained 25%+ EBITDA validate execution. But H2 guidance withheld (vague 'maintain momentum'), ResolX revenue still zero at 5 months, and Netcom integration adds near-term margin pressure. Catalysts (ResolX revenue, margin recovery, acquisition #2) will determine FY27 ₹600-700 Cr target achievement and long-term value creation.

₹175 Cr

Revenue · +147% YoY

₹18.4 Cr

Reported PAT · +56% YoY

Compressing

Margins · vs guidance: Corroborated

Did the claims hold up?

Management's claims vs. the numbers

Strong momentum from organic growth, new accounts, programme ramp-ups

MET

Q2 ₹175 Cr (147% YoY, 10.5% QoQ); EBITDA margin 25.9% despite Netcom acquisition impact

ResolX unlocking larger value engagements, driving long-term growth

OVERSTATED

14 deployments across 7 clients in 5 months; no material revenue contribution yet; timeline vague

FY27 trajectory toward ₹600-700 Cr (doubling), EBITDA 20-25% margins

MET

H1 FY27 ₹333.28 Cr (60% of target); EBITDA margin 25.4% in H1; on track if H2 similar to Q2

Margin compression from Netcom is temporary, one month impact in Q2

MET

OPM fell 600 bps YoY (30.6% to 25.9%); CFO confirmed one month Netcom in Q2; Q1-Q2 trend shows 25% maintained

Quarterly run rates sustainable for next two quarters

Partial

Q2 ₹175 Cr shows strong momentum; H2 guidance withheld; management confident but vague

Earnings quality

What changed since the last call

Deltas vs. the prior call

H2 guidance withheld (no specific numbers)

Neutral

Prior: FY27 ₹600-700 Cr (doubling). This call: 'maintain momentum' + '15-20% organic growth baseline' (vague). Shift from aspirational to cautious despite strong H1 execution.

ResolX revenue timeline vague

Downgrade

Prior: 12-18 months to revenue. This call: 14 deployments at 5 months, 'coming quarters' for material revenue (pushed right). No specific timeline.

Capex guidance withheld

Neutral

Management says 'can't give exact number, within comfortable range.' No clarity on AI product capex or ROI timeline.

Netcom impact disclosed transparently

Neutral

One-month impact in Q2 caused 600 bps OPM compression. Full-quarter hit expected Q3, recovery planned. Adds temporary headwind.

The Q&A

Analysts pressed hard on H2 specifics, Capex numbers, and ResolX revenue timing. Management deflected with 'very difficult to give a number' and 'strong pipeline ahead' language. On margin compression, CFO transparent (Netcom impact disclosed). On ResolX, deflected (no revenue timeline). On FY27 track, confident. Mixed credibility: execution proven, forward visibility lacking.

The exchanges that mattered

H2 guidance — Gautam Bafna, Whitestone Research LLP

Dodged

Karnik: 'Very difficult to give a number at this point. Promising start from first two quarters; will maintain momentum for remaining year.' Added: 'safely looking at 15-20% YoY growth from strategy perspective; if acquisitions come, revenue multiplies.'

ResolX revenue contribution — Gautam Bafna, Whitestone Research LLP

Partial

Rajiv Desai: '14 deployments across 7 clients in 5 months. Adoption moving beyond individual use cases to live enterprise environments. In coming quarter, that can be capitalized maybe.' Clariva: AI-powered document summarization for insurance/healthcare, 99.7% accuracy.

Capex guidance — Darshill Jhaveri, Crown Capital

Dodged

CFO Jha: 'Continue investing in AI platform, further expenditure expected. Can't give exact number, well within comfortable range.' Product under development; depreciation will be charged once revenue line visible.

OPM compression & sustainability — Arjun Thambe, Aurrevia Crest

Answered

CFO: 'Last two quarters maintained 25%. If comparing YoY, that's acquisition impact—one month of Netcom in Q2.' Karnik: 'Quarterly run rates sustainable, in line with projections for next two quarters. Long-term contracts provide revenue visibility.'

Debt & FY27 track — Arjun Thambe, Aurrevia Crest

Answered

CFO: 'Debt-free company overall. One debt for Netcom acquisition: ₹14.75 M @ 9% cost. Based on current run rate and FY27 projection, well on track.'

ResolX deployments & future revenue — Raghav Sharma, Equidor Capital

Partial

Rajiv Desai: 'Deployed across 14 engagements, 7 clients, spanning insurance/aviation/banking/automotive/digital assets. Existing customers adding workflows, new deployments progressing to live. Strong pipeline for entire year.' On margins: 'AI + manpower combined deals will enhance margins and market position.'

ResolX pricing model & revenue segmentation — Gautam Bafna, Whitestone Research LLP

Partial

Rajiv Desai: 'Not charging platform fee. One-time integration + deployment fee, then consumption-based on resolution provided. Will segregate ResolX revenue in upcoming quarters for visibility. Currently all entities linked to parent billing.'

Guidance

Forward guidance and management's confidence

FY27 ₹600-700 Cr (implicit doubling from ~₹300 Cr FY26 base)

High

H1 FY27 ₹333.28 Cr (60% of range). Current run rate on track. H2 needs ₹267-367 Cr; Q2 was ₹175 Cr, so momentum must sustain or slightly decelerate.

Organic growth baseline 15-20% YoY 'from strategy perspective' (excluding M&A)

Medium

Vague comment on forward growth, organic only. Actual H1 growth 138% includes M&A synergy. Organic baseline conservative vs. actual delivery.

ResolX revenue ramp in 'coming quarters' (Q3/Q4 FY27)

Low

14 deployments at 5 months, no material revenue yet. Timeline vague. CFO: 'can be capitalized maybe' in Q3. Uncertain on materiality.

EBITDA margin 20-25% maintained for FY27

High

Q1 24.9%, Q2 25.9%, H1 25.4%. Netcom impact temporary (one month in Q2). Full impact expected Q3, recovery thereafter. Management committed to 25% steady state.

Operating margin sustainable at ~25% for next two quarters post-Netcom integration

Medium

Current OPM 25.9% (vs. 30.6% YoY). Improvement expected as Netcom scales and AI deals enhance pricing. Timing on full recovery TBD.

AI platform capex 'within comfortable range,' no specific amount

Low

₹80 Cr CWIP on balance sheet (ResolX, Clariva, Omvia R&D). No depreciation yet (pre-revenue). Timeline to product launch and revenue opaque.

Risks the call surfaced

Ranked by how much they should concern a holder

ResolX revenue timing

High

14 deployments across 7 clients at 5 months old. No material revenue contribution yet. Timeline for conversion to revenue is vague ('coming quarters'). If delays extend beyond H2 FY27, long-term growth thesis significantly damaged.

Netcom margin pressure

Medium

Netcom acquisition caused 600 bps YoY OPM compression (30.6% to 25.9%). One month of Q2 impact disclosed. Full quarter impact expected Q3. If integration costs exceed guidance or timeline extends, margin recovery delayed.

H2 execution risk

High

No specific H2 FY27 guidance. Management vague on targets ('maintain momentum'). If quarterly revenue falls below ₹175 Cr in H2, FY27 ₹600-700 Cr doubling target missed. Guidance credibility damaged.

AI capex ROI risk

Medium

₹80 Cr CWIP (R&D for ResolX, Clariva, Omvia). No depreciation yet (pre-revenue). Capex guidance opaque. If product launches slip or adoption disappoints, capex becomes sunk cost, pressuring near-term profitability.

Customer concentration

Medium

Large enterprise wins disclosed (India utility ₹39.32 Cr, Costa Rica $10.8 M, VRL Logistics, security depositary). Customer concentration % not disclosed. If top 5 customers exceed 40% of revenue, dependency risk significant.

M&A execution risk

Medium

Netcom integration underway; plan two more acquisitions within next 3 years targeting North America Fortune 500. Multiple simultaneous M&A increases execution and integration complexity.

Management

Score 7/10. Transparent on execution metrics (deal wins, ResolX deployments, Netcom impact disclosed openly). Evasive on forward guidance ('very difficult to give a number'). Confident on long-term strategy but vague on H2 and AI product timelines. Strong track record on H1 FY27 (138% YoY growth, 25%+ EBITDA margins sustained). Met implied doubling trajectory; quarterly momentum described as sustainable. ResolX 14 deployments in 5 months demonstrates execution capability, but revenue conversion timing unclear.

What to watch next
  • 1 · Q3 FY27 (Oct-Dec 2026)

    ResolX first revenue contribution visible; Netcom full-month P&L impact; margin recovery trajectory clear

  • 2 · H2 FY27 (Jan-Mar 2027)

    Acquisition #2 announced; operating margin stabilization as Netcom integrates; AI wins expansion

  • 3 · FY28 guidance (Apr-Jun 2027)

    ResolX revenue model clarity (license vs. outcome pricing); Clariva adoption trajectory; FY27 full-year results vs. ₹600-700 Cr target

Catalysts (ResolX revenue, margin recovery, acquisition #2) will determine FY27 ₹600-700 Cr target achievement and long-term value creation.

Informational and educational content only. Not investment advice.